SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression.

Yunyi XuMiao XuXinglan LiXin WengZhengzheng SuMengni ZhangJunya TanHao ZengXun LiLing NieJing GongNi ChenXueqin ChenQiao Zhou

Published in: The Prostate (2022)

These findings showed a novel SOX9/HMGB3/NANOG regulatory mechanism, deregulation of which played important roles in PCa progression.

Keyphrases